MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
155 hedge funds and large institutions have $1.21B invested in Momenta Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less call options, than puts
Call options by funds: $984K | Put options by funds: $1.01M
15% less capital invested
Capital invested by funds: $1.42B → $1.21B (-$218M)
Holders
155
Holding in Top 10
1
Calls
$984K
Puts
$1.01M
Top Buyers
| 1 | +$10M | |
| 2 | +$5.64M | |
| 3 | +$5.46M | |
| 4 |
Morgan Stanley
New York
|
+$5.02M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$4.75M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$9.92M | |
| 3 | -$6.22M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.85M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.6M |